Fracture risks and their mechanisms in atopic dermatitis, focusing on receptor activator of nuclear factor kappa-B ligand

About this course

  • Released:
  • Expires: October 16, 2028

Target Audience

This activity is intended for practicing dermatologists and other physicians involved in the treatment and management of diseases of the skin.

Learning Objective

To obtain current knowledge of the fracture risks and their pathogenesis in patients with atopic dermatitis (AD).

Accreditation and Designation Statement

Once the test is passed, a certificate of completion will be generated. The learning activity can be added to the Royal College of Physicians' CPD diary as a self-certified entry.

Activity Disclosures

No commercial support has been accepted related to the development or publication of this activity.